Naphtha Shock: Wave 1 – Shortages, Wave 2 – Price Hikes? A Crisis Looms for Medical Facilities… With 70% of Hospitals Nationwide Operating at a Loss, the Risk of Healthcare Collapse is Real [Kunihiko Oishi Commentary] (CBC TV) – Yahoo! News

News Highlights

According to a report by CBC Television, the surge in naphtha prices is bringing a dual crisis of “shortages” and “price increases” to the medical field. With approximately 70% of medical institutions nationwide operating at a loss, this situation could further escalate the risk of healthcare collapse. In particular, the rising procurement costs for pharmaceuticals and medical supplies are pressuring management and could have a serious impact on the sustainability of regional healthcare.

Perspective from M&A Medical Editorial Department

The impact of the naphtha shock on the medical field extends beyond mere cost increases; it poses a threat to the pharmaceutical and medical supply chain itself. In a situation where 70% of institutions are already operating at a loss, further increases in procurement costs and shortages will fundamentally shake the management base of medical facilities that have been barely maintaining operations. Small and medium-sized clinics and hospitals, especially those deeply rooted in their communities, often find it difficult to pass on costs, making them highly susceptible to deteriorating current ratios and consecutive losses. In this context, for cases where the clinic director bears personal joint liability, the impact on personal assets cannot be ignored if business improvement is not expected. By considering business succession, including M&A, at an early stage, the possibility of mitigating these risks and securing better options for patient and staff employment, as well as the continuation of regional healthcare, increases.

Key Discussion Points from This News

• The surge in naphtha prices is causing a dual blow of “shortages” and “price increases” that pressure the management of medical institutions.
• Amidst the severe situation of 70% of institutions operating at a loss nationwide, cost increases amplify the risk of healthcare collapse.
• Small and medium-sized medical institutions, which bear the responsibility for regional healthcare, are disproportionately affected by the difficulty in passing on costs.
• Negotiations for the release of personal guarantees may be more favorably advanced through M&A while the business is still financially sound.

Practical Questions Arising from This News

• To what extent are pharmaceuticals and medical supplies likely to increase in price?
• What conditions would make it possible for a medical institution operating at a loss to consider an M&A?
• To what extent is the release of personal guarantees realistic in M&A negotiations?

If You Feel “Should I Consult Too?”

Let’s specifically calculate the extent to which the cost increases due to the naphtha shock may impact your institution’s management. If a deteriorating current ratio, a decline in operating profit margin, or consecutive losses are anticipated, it is crucial to consult with an expert promptly. Early consultation can broaden the options for business succession through M&A and increase the likelihood of securing more favorable terms, such as the release of the director’s personal joint liability and the continuation of regional healthcare.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a business succession support institution certified by the Small and Medium Enterprise Agency, with a completely success-fee-only basis. Consultations are accepted with strict confidentiality. Free consultation here